期刊文献+

特异性针对大鼠甲状旁腺激素受体1基因SiRNA表达载体的构建、鉴定及对高糖状态下INS-1细胞周期的影响 被引量:3

Construction and identification of siRNA recombinant expression vector targeting parathyroid hormone 1 receptor gene and its effect on the cell cycle of INS-1 cells
下载PDF
导出
摘要 目的构建并筛选携带针对大鼠甲状旁腺激素受体1基因(PTH1R)的pSUPERretro-GFP/Neo干扰逆转录病毒载体以及鉴定及观测高糖下对INS-1细胞周期的影响。方法根据Genbank筛选PTH1R三个阳性克隆及一个阴性克隆序列,定向克隆入逆转录病毒载体pSUPERretro-GFP/Neo,并用RT-PCR和测序鉴定,将其转染至INS-1细胞中,Westernblotting观察PTH1R表达,鉴定其转染效率,筛选出最佳抑制基因后,应用流式细胞仪检测25mmol/LD-葡萄糖处理INS-1细胞周期。结果菌落RT-PCR及基因测序鉴定结果表明序列正确。并能成功转染到INS-1细胞株中,Westernblot筛选最佳抑制基因。细胞周期检测提示PTH1R沉默后抑制INS-1细胞从G0/G1期进入S期。结论成功构建并筛选出特异性沉默大鼠甲状旁腺激素受体1基因的pSUPERretro-GFP/Neo干扰逆转录病毒载体,高糖状态下PTH1R表达可能为INS-1细胞自我保护的一种作用。 Objective To constructthe expressionvectorof siRNA targeting parathyroid hormone 1 receptor(PTH1R) gene and evaluate its effectonthe cell cycle of INS-1 cells.Methods The sequences of PTH1Rgene was retrievedfromGenbank,and4 pairs of oligonucleotides were synthesizedandinsertedinto pSUPERretro RNAi,whichwas identifiedby RT-PCRandsequence analysis.The vectors were thentransfectedinto INS-1 cells,inwhichthe expressionof PTH1Rwas observedby Westernblotting to evaluate the transfection efficiency.The cell cycle of INS-1 cells in high glucose medium was detected by flow cytometry.Results RT-PCR and sequence analysis confirmed the correct construction of the siRNA recombinant expression vector targeting PTH1R gene.The vectors were successfully transfected into INS-1 cells,and the most effective vectorwas selected by Westernblotting.Transfectionwiththe siRNA forPTH1Rgene silencing resultedinthe inhibitionof INS-1 formentering the S phase.Conclusion The successful constructionof the recombinantPTH1R-siRNA vectors establishes abasis forfurtherstudy of protective role of the PTH1Rgene inINS-1 cells inhighglucose medium.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2010年第9期2093-2096,共4页 Journal of Southern Medical University
基金 广西科技厅自然科学基金(0991294) 广西北海市科学研究与技术开发计划项目(200901059)
关键词 甲状旁腺激素受体1基因 小干扰RNA 小发卡结构RNA 转染 RNA干扰 细胞周期 parathyroid hormone 1 receptor small interfering RNA small hairpin RNA gene transfection RNA interference cell cycle
  • 相关文献

参考文献12

  • 1杨贵忠,余华荣,袁野,周岐新,刘颖菊.RNAi抑制CYP3A4基因表达的实验研究[J].南方医科大学学报,2008,28(12):2227-2229. 被引量:1
  • 2Vasavada RC, Gonzalez-Pertusa JA, Fujinaka Y, et al. Growth factors and beta cell replication [J]. Int J Biochem Cell Biol, 2006, 38(5-6): 931-50.
  • 3Pads M, Tourrel-Cuzin C, Plachot C, et al. Pancreatic beta-cell neogenesis revisited[ J ]. Exp Diabesity Res, 2004, 5(2): 111-21.
  • 4Fujinaka Y, Sipula D, Garcia-Ocana A, et al. Characterization of mice doubly transgenic for parathyroid hormone-related protein and murine placental lactogen: a novel role for placental lactogen in pancreatic beta-cell survival [ J ]. Diabetes, 2004, 53( 12): 3120-30.
  • 5Zhang B, Hosaka M, Sawada Y, et al. Parathyroid hormone-related protein induces insulin expression through activation of MAP kinase-specific phosphatase-I that dephosphorylates c-Jun NH2-terminal kinase in pancreatic beta-cells [J ]. Diabetes, 2003, 52 (11): 2720-30.
  • 6Dittmer A, Vetter M, Schunke D, et al. Parathyroid hormone-related protein regulates tumor-relevant genes in breast cancer cells [J]. J Biol Chem, 2006, 281(21): 14563-72.
  • 7Alokail MS, Peddie MJ. Quantitative comparison of PTH1R in breast cancer MCF7 and osteosarcoma SaOS-2 cell lines [J]. Cell Biochem Funct, 2008, 26(4): 522-33.
  • 8Vasavada RC, Wang L, Fujinaka Y, et al. Protein kinase C-zeta activation markedly enhances beta-cell proliferation: an essential role in growth factor mediated beta-cell mitogenesis [J]. Diabetes, 2007, 56(11): 2732-43.
  • 9Men X, Wang H, Li M, et al. Dynamin-related protein l mediates high glucose induced pancreatic beta cell apoptosis [J ]. Int J Biochem Cell Biol, 2009, 41(4): 879-90.
  • 10Iguchi H, Urashima Y, Inagaki Y, et al. SOX6 suppresses cyclin D1 promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferation[J]. J Biol Chem, 2007, 282(26): 19052-61.

二级参考文献5

  • 1Shankar P, Martjunath N, Lieberman J. The prospect of silencing disease using RNA interference[J]. JAMA, 2005, 293 (11): 1367-73.
  • 2Hariparsad N, Sane RS, Strom SC, et al. In vitro methods in human drug bio-transformation research: implications for cancer chemotherapy[J].Toxicol in Vitro, 2006, 20(2): 135-53.
  • 3Lu AY, Wang RW, Lin JH. Cytochrome P450 in vitro reaction phemotyping : a revaluation of approaches used for P450 isoform identification[J]. Drug Metab Dispos, 2003, 31(4): 345-50.
  • 4Thompson JD. Applications of antisense and siRNAs during preclinical drug development [J ]. Drug Discov Today, 2002, 7(17): 912-7.
  • 5Sijen T, Steiner FA, Thijssen KL, et al. Secondary siRNAs result from unprimed RNA synthesis and form a distinct class[J].Science, 2007, 315(5809): 244-7.

同被引文献25

  • 1蔡大勇,王坚.女性中枢性甲状腺功能减退的临床分析[J].东南国防医药,2011,13(3):197-199. 被引量:1
  • 2Albright F,Burnett CH,Smithp H,et al.Pseudo-hypopara-thyroidism:an example of Seabright-Bantam syndrome[J].Endoerinology,1942,30:922-3.
  • 3Spiegel AM,Shenker A,Weinstein LS.Receptor-effector couplingby G proteins:implications for normal and abnormal signaltransduction[J].Endocr Rev,1992,13(3):536-65.
  • 4Renuka RB,Roger T,Robert R.Pseudohypo parathyroidism withhypercalcemia[J].Endocr,2001,10:347-9.
  • 5Mantovani G,Ferrante E,Giavoli C,et al.Recombinant human GHreplacement therapy in children with pseudohypoparathyroidismtype Ia:first study on the effect on growth[J].J Clin EndocrinolMetab,2010,95(11):5011-7.
  • 6Donghi V, Mora S,Zamproni I, et al. Pseudohypopara- thyroidism, an often delayed diagnosis: a case series [J]. Cases J,2009,2:6734.
  • 7Albright F, Burnett CH, Smithp H, et al. Pseudo-hy- poparathyroidism: an example of Seabright-Bantam syndrome [J]. Endoerinology, 1942, 30: 922-923.
  • 8Nakamura Y, Matsumoto T, Tamakoshi A, et al. Prev- alence of idiopathic hypoparathyroidism and pseudohy- poparathyroidism in Japan [J ]. J Epidemiol, 2000, 10 (1) :29-33.
  • 9Spiegel AM, Shenker A, Weinstein LS. Receptor-el- lector coupling by G proteins: implications for normal and abnormal signal transduction [J]. Endoer Rev, 1992: 13(3): 536-65.
  • 10Bringhurst FR, Demay MB, Kronenberg HM. Hor- moneand disorders of mineral metabolism[A]. In: WilsonJD, Foster DW, Kronenberg HN, et al. Wil- liams Text-book of Endocrinology[M]. 9th Edition. Philadelphia: W. BSaunders Company, 2001: 1155- 1210.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部